Organovo Holdings, Inc. (ONVO) Executive Compensation

Organovo Holdings, Inc.

ONVO (NASDAQ)

(%)

Ownership
Organovo Holdings, Inc. Executive Compensation

* In original currency USD

Loading Data

Filing Date (SEC Report)	Year	Reporting Name	Salary	Bonus	Stock Award	Incentive Plan Compensation	Other Compensation	Total Amount
Monday, November 3rd, 2025	2025	Thomas Hess Former Chief Financial Officer	114,975	0	0	0	0	114,975
Monday, November 3rd, 2025	2024	Thomas Hess Former Chief Financial Officer	199,322	0	0	0	0	199,322
Monday, November 3rd, 2025	2025	Norman Staskey Chief Financial Officer	20,925	0	0	0	0	20,925
Monday, November 3rd, 2025	2024	Keith Murphy Executive Chairman	657,984	0	0	0	23,152	681,136
Monday, November 3rd, 2025	2025	Keith Murphy Executive Chairman	726,674	0	0	0	10,870	1,165,657
Monday, October 7th, 2024	2024	Thomas Jurgensen Former General Counsel and Corporate Secretary	161,446	0	0	0	348,454	509,900
Monday, October 7th, 2024	2024	Keith Murphy Executive Chairman	657,984	0	0	0	23,152	681,136
Monday, October 7th, 2024	2023	Jeffrey Miner Former Chief Scientific Officer	238,292	0	0	0	3,540	315,753
Monday, October 7th, 2024	2024	Jeffrey Miner Former Chief Scientific Officer	100,904	0	0	0	172,790	320,031
Monday, October 7th, 2024	2023	Thomas Jurgensen Former General Counsel and Corporate Secretary	381,263	0	0	0	10,790	465,974
Monday, October 7th, 2024	2024	Thomas Hess Chief Financial Officer	199,322	0	0	0	0	199,322
Monday, October 7th, 2024	2023	Keith Murphy Executive Chairman	543,781	0	0	0	3,746	621,448
Wednesday, September 13th, 2023	2023	Jeffrey Miner Former Chief Scientific Officer	238,292	0	0	0	3,540	315,753
Wednesday, September 13th, 2023	2022	Jeffrey Miner Former Chief Scientific Officer	225,000	0	0	78,750	0	747,027
Wednesday, September 13th, 2023	2022	Thomas Jurgensen Former General Counsel and Corporate Secretary	360,000	0	0	180,000	8,029	812,083
Wednesday, September 13th, 2023	2023	Thomas Jurgensen Former General Counsel and Corporate Secretary	381,263	0	0	0	10,790	465,974
Wednesday, September 13th, 2023	2022	Keith Murphy Executive Chairman	430,073	0	0	0	400	1,260,144
Wednesday, September 13th, 2023	2023	Keith Murphy Executive Chairman	543,781	0	0	0	3,746	621,448
Tuesday, July 26th, 2022	2022	Keith Murphy Executive Chairman	430,073	0	0	0	400	1,260,144
Tuesday, July 26th, 2022	2021	Thomas Jurgensen General Counsel and Corporate Secretary	264,025	0	0	34,338	837	695,683
Tuesday, July 26th, 2022	2022	Thomas Jurgensen General Counsel and Corporate Secretary	360,000	0	0	180,000	8,029	812,083
Tuesday, July 26th, 2022	2021	Jeffrey Miner Chief Scientific Officer	120,288	0	0	42,101	0	953,317
Tuesday, July 26th, 2022	2022	Jeffrey Miner Chief Scientific Officer	225,000	0	0	78,750	0	747,027
Tuesday, July 26th, 2022	2021	Keith Murphy Executive Chairman	354,080	0	205,400	0	0	2,360,645
Thursday, August 5th, 2021	2020	Jennifer Kinsbruner Bush, JD Former SVP, General Counsel, Corporate Secretary and Compliance Officer	357,410	0	353,392	71,482	9,799	792,083
Thursday, August 5th, 2021	2020	Taylor Crouch Former Chairman, Chief Executive Officer, President	515,000	0	989,893	128,750	9,766	1,643,409
Thursday, August 5th, 2021	2021	Craig Kussman Former Chief Financial Officer	253,181	0	0	152,367	834,390	12,399
Thursday, August 5th, 2021	2021	Thomas Jurgensen General Counsel and Corporate Secretary	264,025	0	0	0	837	695,683
Thursday, August 5th, 2021	2021	Jeffrey Miner Chief Scientific Officer	120,288	0	0	0	0	953,317
Thursday, August 5th, 2021	2021	Taylor Crouch Former Chairman, Chief Executive Officer, President	302,562	0	0	247,271	1,059,320	1,609,153
Thursday, August 5th, 2021	2020	Craig Kussman Former Chief Financial Officer	396,675	0	394,968	79,335	9,774	880,752
Thursday, August 5th, 2021	2021	Jennifer Kinsbruner Bush, JD Former SVP, General Counsel, Corporate Secretary and Compliance Officer	164,958	0	0	137,285	719,516	1,021,759
Thursday, August 5th, 2021	2021	Keith Murphy Executive Chairman	354,080	0	205,400	0	0	2,360,645
Thursday, August 6th, 2020	2020	Taylor Crouch Chairman, Chief Executive Officer, President	515,000	0	989,893	128,750	9,766	1,643,409
Thursday, August 6th, 2020	2019	Taylor Crouch Chairman, Chief Executive Officer, President	515,000	0	438,773	226,600	9,778	2,924,208
Thursday, August 6th, 2020	2019	Paul Gallant Former General Manager	288,025	0	121,652	92,168	9,691	1,169,909
Thursday, August 6th, 2020	2020	Paul Gallant Former General Manager	180,344	0	287,069	57,605	309,126	834,144
Thursday, August 6th, 2020	2019	Steven Hughes, M.D. Former Chief Medical Officer	266,667	37,500	0	117,000	11,968	433,135
Thursday, August 6th, 2020	2020	Steven Hughes, M.D. Former Chief Medical Officer	178,779	37,500	593,936	66,885	436,392	1,313,492
Thursday, August 6th, 2020	2020	Craig Kussman Chief Financial Officer	396,675	0	394,968	79,335	9,774	880,752
Thursday, August 6th, 2020	2020	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	357,410	0	353,392	71,482	9,799	792,083
Thursday, August 6th, 2020	2019	Craig Kussman Chief Financial Officer	396,675	0	136,859	142,803	9,717	1,553,083
Thursday, August 6th, 2020	2019	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	357,410	0	129,256	139,390	9,639	1,482,635
Friday, July 26th, 2019	2018	Craig Kussman Chief Financial Officer	387,000	37,500	585,200	140,000	9,572	1,159,272
Friday, July 26th, 2019	2019	Craig Kussman Chief Financial Officer	396,675	0	136,859	142,803	9,717	1,553,083
Friday, July 26th, 2019	2018	Taylor Crouch Chairman, Chief Executive Officer, President	471,154	0	392,582	200,000	14,183	4,825,948
Friday, July 26th, 2019	2019	Taylor Crouch Chairman, Chief Executive Officer, President	515,000	0	438,773	226,600	9,778	2,924,208
Friday, July 26th, 2019	2018	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	351,570	0	598,500	140,000	9,466	1,099,536
Friday, July 26th, 2019	2019	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	357,410	0	129,256	139,390	9,639	1,482,635
Friday, June 15th, 2018	2018	Taylor Crouch Chairman, Chief Executive Officer, President	471,154	0	157,034	200,000	14,183	4,590,400
Friday, June 15th, 2018	2017	Eric David, MD, JD Former Chief Strategy Officer, Executive Vice President of Pre-Clinical Development	334,615	0	199,500	124,090	0	910,761
Friday, June 15th, 2018	2016	Eric David, MD, JD Former Chief Strategy Officer, Executive Vice President of Pre-Clinical Development	324,597	0	0	72,080	0	815,388
Friday, June 15th, 2018	2018	Keith Murphy Former Chairman, Chief Executive Officer, President	89,656	0	0	15,103	3,365	108,124
Friday, June 15th, 2018	2017	Keith Murphy Former Chairman, Chief Executive Officer, President	524,039	0	829,920	227,938	9,390	2,639,394
Friday, June 15th, 2018	2018	Craig Kussman Chief Financial Officer	387,000	37,500	585,200	140,000	9,572	1,159,272
Friday, June 15th, 2018	2017	Craig Kussman Chief Financial Officer	216,346	37,500	529,320	89,599	8,918	1,729,997
Friday, June 15th, 2018	2018	Sharon Presnell, Ph.D. Chief Scientific Officer and President of Samsara Sciences, Inc.	372,000	0	532,000	140,000	0	1,044,000
Friday, June 15th, 2018	2016	Keith Murphy Former Chairman, Chief Executive Officer, President	499,058	0	0	172,000	9,083	2,209,519
Friday, June 15th, 2018	2016	Sharon Presnell, Ph.D. Chief Scientific Officer and President of Samsara Sciences, Inc.	349,462	0	0	86,812	0	854,985
Friday, June 15th, 2018	2017	Sharon Presnell, Ph.D. Chief Scientific Officer and President of Samsara Sciences, Inc.	360,577	0	199,500	118,980	0	931,613
Friday, June 15th, 2018	2018	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	351,570	0	598,500	140,000	9,466	1,099,536
Friday, June 15th, 2018	2017	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	334,615	0	199,500	128,682	9,287	924,640
Friday, June 15th, 2018	2016	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	323,115	20,000	0	88,573	8,624	842,919
Friday, June 15th, 2018	2018	Paul Gallant, General Manager	281,000	0	425,600	73,763	9,121	789,484
Friday, June 15th, 2018	2018	Eric David, MD, JD Former Chief Strategy Officer, Executive Vice President of Pre-Clinical Development	297,231	0	505,400	0	0	802,631
Friday, July 14th, 2017	2016	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	323,115	20,000	0	88,573	8,624	842,919
Friday, July 14th, 2017	2015	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	141,231	20,000	0	44,488	2,504	897,910
Friday, July 14th, 2017	2017	Craig Kussman Chief Financial Officer	216,346	37,500	529,320	89,599	8,918	1,729,997
Friday, July 14th, 2017	2017	Keith Murphy Chairman, Chief Executive Officer, President	524,039	0	829,920	227,938	9,390	2,639,394
Friday, July 14th, 2017	2016	Keith Murphy Chairman, Chief Executive Officer, President	499,058	0	0	172,000	9,083	2,209,519
Friday, July 14th, 2017	2015	Keith Murphy Chairman, Chief Executive Officer, President	469,897	0	0	246,696	3,103	837,532
Friday, July 14th, 2017	2017	Sharon Presnell, Ph.D. Chief Scientific Officer	360,577	0	199,500	118,980	0	931,613
Friday, July 14th, 2017	2016	Sharon Presnell, Ph.D. Chief Scientific Officer	349,462	0	0	86,812	0	854,985
Friday, July 14th, 2017	2015	Sharon Presnell, Ph.D. Chief Scientific Officer	334,715	0	0	115,587	0	450,302
Friday, July 14th, 2017	2017	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	334,615	0	199,500	124,090	0	910,761
Friday, July 14th, 2017	2016	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	324,597	0	0	72,080	0	815,388
Friday, July 14th, 2017	2015	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	315,092	0	0	115,427	0	430,519
Friday, July 14th, 2017	2017	Jennifer Kinsbruner Bush, JD SVP, General Counsel, Corporate Secretary and Compliance Officer	334,615	0	199,500	128,682	9,287	924,640
Friday, July 8th, 2016	2014	Michael Renard Former Executive Vice President of Commercial Operations	268,451	0	0	91,478	0	1,379,891
Friday, July 8th, 2016	2014	Keith Murphy Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer	362,877	0	0	128,052	0	4,681,594
Friday, July 8th, 2016	2016	Sharon Presnell, Ph.D. Chief Scientific Officer	349,462	0	0	86,812	0	854,985
Friday, July 8th, 2016	2015	Sharon Presnell, Ph.D. Chief Scientific Officer	334,715	0	0	115,587	0	450,302
Friday, July 8th, 2016	2016	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	324,597	0	0	72,080	0	815,388
Friday, July 8th, 2016	2015	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	315,092	0	0	115,427	0	430,519
Friday, July 8th, 2016	2014	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	289,805	0	0	81,609	0	1,292,670
Friday, July 8th, 2016	2016	Jennifer Kinsbruner Bush, JD General Counsel, Corporate Secretary and Compliance Officer	323,115	20,000	0	88,573	0	834,295
Friday, July 8th, 2016	2015	Jennifer Kinsbruner Bush, JD General Counsel, Corporate Secretary and Compliance Officer	141,231	20,000	0	44,488	0	895,406
Friday, July 8th, 2016	2016	Barry Michaels Former Chief Financial Officer	344,731	0	0	79,172	0	1,397,636
Friday, July 8th, 2016	2016	Michael Renard Former Executive Vice President of Commercial Operations	180,118	0	0	56,875	325,000	980,704
Friday, July 8th, 2016	2015	Michael Renard Former Executive Vice President of Commercial Operations	312,864	0	0	114,796	0	427,660
Friday, July 8th, 2016	2015	Barry Michaels Former Chief Financial Officer	339,600	0	0	125,200	0	1,009,157
Friday, July 8th, 2016	2016	Keith Murphy Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer	499,058	0	0	172,000	0	2,200,436
Friday, July 8th, 2016	2015	Keith Murphy Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer	469,897	0	0	246,696	0	834,429
Friday, July 10th, 2015	2014	Barry D. Michaels Chief Financial Officer	289,052	0	0	102,926	0	2,755,922
Friday, July 10th, 2015	2012	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	160,968	22,500	0	47,486	28,245	1,016,957
Friday, July 10th, 2015	2012	Sharon Presnell, Ph.D. Chief Technology Officer and Executive Vice President of Research and Development	253,298	0	0	77,537	0	634,831
Friday, July 10th, 2015	2014	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	289,805	0	0	81,609	0	1,292,670
Friday, July 10th, 2015	2014	Keith Murphy Chairman, Chief Executive Officer, and President	362,877	0	0	128,052	0	4,681,594
Friday, July 10th, 2015	2015	Barry D. Michaels Chief Financial Officer	339,600	0	0	125,200	0	1,009,157
Friday, July 10th, 2015	2015	Sharon Presnell, Ph.D. Chief Technology Officer and Executive Vice President of Research and Development	334,715	0	0	115,587	0	450,302
Friday, July 10th, 2015	2015	Keith Murphy Chairman, Chief Executive Officer, and President	469,897	0	0	246,696	0	834,429
Friday, July 10th, 2015	2014	Sharon Presnell, Ph.D. Chief Technology Officer and Executive Vice President of Research and Development	289,052	0	0	90,686	0	1,399,700
Friday, July 10th, 2015	2015	Jennifer Kinsbruner Bush, JD General Counsel, Corporate Secretary and Compliance Officer	141,231	20,000	0	44,488	0	895,406
Friday, July 10th, 2015	2015	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	315,092	0	0	115,427	0	430,519
Friday, July 11th, 2014	2014	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	289,805	0	0	81,609	0	1,292,670
Friday, July 11th, 2014	2012	Michael Renard Executive Vice President of Commercial Operations	156,927	0	0	46,293	40,000	1,002,166
Friday, July 11th, 2014	2014	Michael Renard Executive Vice President of Commercial Operations	268,451	0	0	91,478	0	1,379,891
Friday, July 11th, 2014	2011	Sharon Presnell, PhD Chief Technology Officer and Executive Vice President of Research and Development	157,385	50,000	0	0	24,681	286,701
Friday, July 11th, 2014	2012	Sharon Presnell, PhD Chief Technology Officer and Executive Vice President of Research and Development	253,298	0	0	77,537	0	634,831
Friday, July 11th, 2014	2014	Sharon Presnell, PhD Chief Technology Officer and Executive Vice President of Research and Development	289,052	0	0	90,686	0	1,399,700
Friday, July 11th, 2014	2014	Barry D. Michaels Chief Financial Officer and Corporate Secretary	289,052	0	0	102,926	0	2,755,922
Friday, July 11th, 2014	2012	Keith Murphy Chairman, Chief Executive Officer, and President	298,885	0	680,000	90,667	0	1,069,552
Friday, July 11th, 2014	2014	Keith Murphy Chairman, Chief Executive Officer, and President	362,877	0	0	128,052	0	4,681,594
Friday, July 11th, 2014	2012	Barry D. Michaels Chief Financial Officer and Corporate Secretary	241,889	0	1,275,000	73,967	0	1,825,288
Friday, July 11th, 2014	2011	Michael Renard Executive Vice President of Commercial Operations	0	0	0	0	0	0
Friday, July 12th, 2013	2012	Keith Murphy Chairman, Chief Executive Officer, and President	298,885	0	680,000	90,667	0	1,069,552
Friday, July 12th, 2013	2010	Executive Vice President of Commercial Operations	0	0	0	0	0	0
Friday, July 12th, 2013	2011	Michael Renard Executive Vice President of Commercial Operations	0	0	0	0	0	0
Friday, July 12th, 2013	2012	Michael Renard Executive Vice President of Commercial Operations	156,927	0	0	46,293	40,000	1,002,166
Friday, July 12th, 2013	2010	Chief Strategy Officer	0	0	0	0	0	0
Friday, July 12th, 2013	2011	Chief Strategy Officer	0	0	0	0	0	0
Friday, July 12th, 2013	2012	Eric David, MD, JD Chief Strategy Officer and Executive Vice President of Pre-Clinical Development	160,968	22,500	0	47,486	28,245	1,016,957
Friday, July 12th, 2013	2010	Chief Technology Officer and Executive Vice President of Research and Development	0	0	0	0	0	0
Friday, July 12th, 2013	2011	Sharon Presnell, PhD Chief Technology Officer and Executive Vice President of Research and Development	157,385	50,000	0	0	24,681	286,701
Friday, July 12th, 2013	2011	Chief Financial Officer and Corporate Secretary	74,315	25,000	0	0	0	99,315
Friday, July 12th, 2013	2011	Chairman, Chief Executive Officer, and President	217,711	30,000	0	0	0	247,711
Friday, July 12th, 2013	2010	Keith Murphy Chairman, Chief Executive Officer, and President	110,000	0	0	0	0	110,000
Friday, July 12th, 2013	2012	Barry D. Michaels Chief Financial Officer and Corporate Secretary	241,889	0	1,275,000	73,967	0	1,825,288
Friday, July 12th, 2013	2010	Chief Financial Officer and Corporate Secretary	0	0	0	0	0	0
Friday, July 12th, 2013	2012	Sharon Presnell, Ph.D. Chief Technology Officer and Executive Vice President of Research and Development	253,298	0	0	77,537	0	634,831
Monday, September 17th, 2012	2010	Keith Murphy Chairman, Chief Executive Officer, and President	46,538	0	0	0	0	110,000
Monday, September 17th, 2012	2011	Keith Murphy Chairman, Chief Executive Officer, and President	217,711	0	0	0	0	217,711
Monday, September 17th, 2012	2011	Barry D. Michaels, Chief Financial Officer	74,315	0	0	0	0	74,315
Monday, September 17th, 2012	2011	Sharon Presnell, Executive Vice-President of Research and Development	157,385	0	0	0	0	160,548

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Organovo Holdings, Inc. Executive Compensation